Abbvie is an API and finished-dose manufacturer based in United States. It holds 7 active US drug master files and 6 valid CEPs across a filed portfolio of 8 molecules. Its filings concentrate with Health Canada, US FDA and EMA. Its GMP standing is certified by EAEU_EEC, ZLG (DE) and HSA (SG), among 14 authorities. Its most recent recorded inspection, by US FDA, closed on 3 March 2026 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| North Chicago, United Arab Emirates | Not on file |
| Pringy, United Arab Emirates | Not on file |
| Westport, United Arab Emirates | Not on file |
| Texas 76712, United Arab Emirates | Not on file |
| HIMACHAL PRADESH, United Arab Emirates | Not on file |
| Ludwigshafen, United Arab Emirates | Not on file |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Erythromycin | EDQM, US FDA | 6 |
| Cyclosporine | EDQM, US FDA | 2 |
| Biperiden | EDQM | 1 |
| Butorphanol | US FDA | 1 |
| Isoflurane | EDQM | 1 |
| Oritavancin Diphosphate | SFDA (Saudi Arabia) | 1 |
| Paricalcitol | US FDA | 1 |
| Ritonavir | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| Health Canada | 451 | None |
| US FDA | 390 | 5 |
| EMA | 252 | 9 |
| INFARMED (PT) | 250 | None |
| FAMHP (BE) | 167 | None |
| AIFA (IT) | 162 | None |
| EAEU_EEC | None | 15 |
| ZLG (DE) | None | 14 |
| HSA (SG) | None | 12 |
| NAFDAC (NG) | None | 12 |
| ANSM (FR) | None | 9 |
| MFDS (Korea) | None | 6 |
| TMDA (TZ) | None | 5 |
| MHRA (UK) | None | 5 |
| FDA (GH) | None | 4 |
| NCELS (KZ) | None | 4 |
| ANVISA (Brazil) | None | 3 |
| SAHPRA (ZA) | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | $16.6B | Not reported | Not reported |
| 2024 | $15.1B | Not reported | Not reported |
| 2023 | $14.3B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Abbvie comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.